Neither the specificity of SMCHD1 or of DUX4 expression nor of its target genes identified so far [18]–[21], [23]–[24], provide sufficient account for the specificity of the muscle map and the non-muscular symptoms that characterize FSHD. Here, DUX4 is linked to Facioscapulohumeral dystrophy.